Literature DB >> 27514584

RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells.

A Rasim Barutcu1, Deli Hong2, Bryan R Lajoie3, Rachel Patton McCord3, Andre J van Wijnen4, Jane B Lian2, Janet L Stein2, Job Dekker5, Anthony N Imbalzano6, Gary S Stein7.   

Abstract

RUNX1 is a transcription factor functioning both as an oncogene and a tumor suppressor in breast cancer. RUNX1 alters chromatin structure in cooperation with chromatin modifier and remodeling enzymes. In this study, we examined the relationship between RUNX1-mediated transcription and genome organization. We characterized genome-wide RUNX1 localization and performed RNA-seq and Hi-C in RUNX1-depleted and control MCF-7 breast cancer cells. RNA-seq analysis showed that RUNX1 depletion led to up-regulation of genes associated with chromatin structure and down-regulation of genes related to extracellular matrix biology, as well as NEAT1 and MALAT1 lncRNAs. Our ChIP-Seq analysis supports a prominent role for RUNX1 in transcriptional activation. About 30% of all RUNX1 binding sites were intergenic, indicating diverse roles in promoter and enhancer regulation and suggesting additional functions for RUNX1. Hi-C analysis of RUNX1-depleted cells demonstrated that overall three-dimensional genome organization is largely intact, but indicated enhanced association of RUNX1 near Topologically Associating Domain (TAD) boundaries and alterations in long-range interactions. These results suggest an architectural role for RUNX1 in fine-tuning local interactions rather than in global organization. Our results provide novel insight into RUNX1-mediated perturbations of higher-order genome organization that are functionally linked with RUNX1-dependent compromised gene expression in breast cancer cells.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Breast cancer; Hi-C; MCF-7; RUNX1; TAD; Topologically associating domain

Mesh:

Substances:

Year:  2016        PMID: 27514584      PMCID: PMC5071180          DOI: 10.1016/j.bbagrm.2016.08.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  69 in total

1.  A molecular signature of metastasis in primary solid tumors.

Authors:  Sridhar Ramaswamy; Ken N Ross; Eric S Lander; Todd R Golub
Journal:  Nat Genet       Date:  2002-12-09       Impact factor: 38.330

Review 2.  Oncogenic potential of the RUNX gene family: 'overview'.

Authors:  Yoshiaki Ito
Journal:  Oncogene       Date:  2004-05-24       Impact factor: 9.867

Review 3.  Nuclear structure in cancer cells.

Authors:  Daniele Zink; Andrew H Fischer; Jeffrey A Nickerson
Journal:  Nat Rev Cancer       Date:  2004-09       Impact factor: 60.716

Review 4.  Point mutations of the RUNx1/AML1 gene in sporadic and familial myeloid leukemias.

Authors:  M Osato; M Yanagida; K Shigesada; Y Ito
Journal:  Int J Hematol       Date:  2001-10       Impact factor: 2.490

Review 5.  The RUNX genes: gain or loss of function in cancer.

Authors:  Karen Blyth; Ewan R Cameron; James C Neil
Journal:  Nat Rev Cancer       Date:  2005-05       Impact factor: 60.716

6.  Proviral insertion indicates a dominant oncogenic role for Runx1/AML-1 in T-cell lymphoma.

Authors:  Sandy Wotton; Monica Stewart; Karen Blyth; Francois Vaillant; Anna Kilbey; James C Neil; Ewan R Cameron
Journal:  Cancer Res       Date:  2002-12-15       Impact factor: 12.701

7.  Transcription factors RUNX1/AML1 and RUNX2/Cbfa1 dynamically associate with stationary subnuclear domains.

Authors:  Kimberly S Harrington; Amjad Javed; Hicham Drissi; Sandra McNeil; Jane B Lian; Janet L Stein; André J Van Wijnen; Yu-Li Wang; Gary S Stein
Journal:  J Cell Sci       Date:  2002-11-01       Impact factor: 5.285

8.  Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations.

Authors:  H Niimi; H Harada; Y Harada; Y Ding; J Imagawa; T Inaba; T Kyo; A Kimura
Journal:  Leukemia       Date:  2006-04       Impact factor: 11.528

Review 9.  Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia.

Authors:  Motomi Osato
Journal:  Oncogene       Date:  2004-05-24       Impact factor: 9.867

Review 10.  Role of RUNX family members in transcriptional repression and gene silencing.

Authors:  Kristie L Durst; Scott W Hiebert
Journal:  Oncogene       Date:  2004-05-24       Impact factor: 9.867

View more
  29 in total

1.  Intranuclear and higher-order chromatin organization of the major histone gene cluster in breast cancer.

Authors:  Andrew J Fritz; Prachi N Ghule; Joseph R Boyd; Coralee E Tye; Natalie A Page; Deli Hong; David J Shirley; Adam S Weinheimer; Ahmet R Barutcu; Diana L Gerrard; Seth Frietze; Andre J van Wijnen; Sayyed K Zaidi; Anthony N Imbalzano; Jane B Lian; Janet L Stein; Gary S Stein
Journal:  J Cell Physiol       Date:  2017-06-22       Impact factor: 6.384

2.  Identification of tRNA-derived small RNA (tsRNA) responsive to the tumor suppressor, RUNX1, in breast cancer.

Authors:  Nicholas H Farina; Stephanie Scalia; Caroline E Adams; Deli Hong; Andrew J Fritz; Terri L Messier; Veronica Balatti; Dario Veneziano; Jane B Lian; Carlo M Croce; Gary S Stein; Janet L Stein
Journal:  J Cell Physiol       Date:  2020-01-10       Impact factor: 6.384

Review 3.  Higher order genomic organization and epigenetic control maintain cellular identity and prevent breast cancer.

Authors:  A J Fritz; N E Gillis; D L Gerrard; P D Rodriguez; D Hong; J T Rose; P N Ghule; E L Bolf; J A Gordon; C E Tye; J R Boyd; K M Tracy; J A Nickerson; A J van Wijnen; A N Imbalzano; J L Heath; S E Frietze; S K Zaidi; F E Carr; J B Lian; J L Stein; G S Stein
Journal:  Genes Chromosomes Cancer       Date:  2019-03-15       Impact factor: 5.006

4.  Apical cell protrusions cause vertical deformation of the soft cancer nucleus.

Authors:  Ian A Kent; Qiao Zhang; Aditya Katiyar; Yuan Li; Shreya Pathak; Richard B Dickinson; Tanmay P Lele
Journal:  J Cell Physiol       Date:  2019-04-21       Impact factor: 6.384

Review 5.  Seeing the forest through the trees: prioritising potentially functional interactions from Hi-C.

Authors:  Ning Liu; Wai Yee Low; Hamid Alinejad-Rokny; Stephen Pederson; Timothy Sadlon; Simon Barry; James Breen
Journal:  Epigenetics Chromatin       Date:  2021-08-28       Impact factor: 4.954

Review 6.  Nuclear organization mediates cancer-compromised genetic and epigenetic control.

Authors:  Sayyed K Zaidi; Andrew J Fritz; Kirsten M Tracy; Jonathan A Gordon; Coralee E Tye; Joseph Boyd; Andre J Van Wijnen; Jeffrey A Nickerson; Antony N Imbalzano; Jane B Lian; Janet L Stein; Gary S Stein
Journal:  Adv Biol Regul       Date:  2018-05-09

7.  Suppression of Breast Cancer Stem Cells and Tumor Growth by the RUNX1 Transcription Factor.

Authors:  Deli Hong; Andrew J Fritz; Kristiaan H Finstad; Mark P Fitzgerald; Adam Weinheimer; Adam L Viens; Jon Ramsey; Janet L Stein; Jane B Lian; Gary S Stein
Journal:  Mol Cancer Res       Date:  2018-08-06       Impact factor: 5.852

Review 8.  Tales from topographic oceans: topologically associated domains and cancer.

Authors:  Moray J Campbell
Journal:  Endocr Relat Cancer       Date:  2019-11       Impact factor: 5.678

Review 9.  Higher order genomic organization and regulatory compartmentalization for cell cycle control at the G1/S-phase transition.

Authors:  Prachi N Ghule; David J Seward; Andrew J Fritz; Joseph R Boyd; Andre J van Wijnen; Jane B Lian; Janet L Stein; Gary S Stein
Journal:  J Cell Physiol       Date:  2018-05-10       Impact factor: 6.384

10.  Integrative detection and analysis of structural variation in cancer genomes.

Authors:  Jesse R Dixon; Jie Xu; Vishnu Dileep; Ye Zhan; Fan Song; Victoria T Le; Galip Gürkan Yardımcı; Abhijit Chakraborty; Darrin V Bann; Yanli Wang; Royden Clark; Lijun Zhang; Hongbo Yang; Tingting Liu; Sriranga Iyyanki; Lin An; Christopher Pool; Takayo Sasaki; Juan Carlos Rivera-Mulia; Hakan Ozadam; Bryan R Lajoie; Rajinder Kaul; Michael Buckley; Kristen Lee; Morgan Diegel; Dubravka Pezic; Christina Ernst; Suzana Hadjur; Duncan T Odom; John A Stamatoyannopoulos; James R Broach; Ross C Hardison; Ferhat Ay; William Stafford Noble; Job Dekker; David M Gilbert; Feng Yue
Journal:  Nat Genet       Date:  2018-09-10       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.